Megestrol Acetate Dosing for Cancer-Related Anorexia

Dosing Recommendations

• The National Comprehensive Cancer Network recommends megestrol acetate as an established appetite stimulant with proven efficacy for cancer patients experiencing anorexia, with a level of evidence of B1 1, 2, 3
• The minimum effective dose is 160 mg daily, which is considered the optimal starting dose, according to the British Journal of Cancer 4, 5
• 200 mg daily has been specifically identified as an effective dose in published trials for improving appetite in cancer patients, as reported by the British Journal of Cancer 6, 7

Safety Considerations and Monitoring

• The Journal of the National Comprehensive Cancer Network notes that megestrol acetate carries a risk of thromboembolic events, particularly at higher doses, and one in six patients treated may develop thromboembolic phenomena 8, 9
• Other potential side effects include edema, impotence, and vaginal spotting, as reported by Clinical Nutrition 8
• Patients should be monitored for weight gain, appetite improvement, and potential adverse effects throughout treatment, as recommended by the Journal of the National Comprehensive Cancer Network 9